Figure 1.
Graphical overview about overall survival (OS) and progression-free survival (PFS). All patients considered in this retrospective analysis were presented, arranged by group in ascending order of PFS: HD-MTX-naïve patients (Group 1) and patients after MTX discontinuation (Group 2). An OS or PFS over the 12-month period shown was marked with an arrow. Cartoon created with Biorender.com (BioRender.com/k37r166).

Graphical overview about overall survival (OS) and progression-free survival (PFS). All patients considered in this retrospective analysis were presented, arranged by group in ascending order of PFS: HD-MTX-naïve patients (Group 1) and patients after MTX discontinuation (Group 2). An OS or PFS over the 12-month period shown was marked with an arrow. Cartoon created with Biorender.com (BioRender.com/k37r166).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close